Pelvic Pain Syndrome Clinical Trial
— UPS-IULOfficial title:
Monocentric, Prospective Pilot Study to Test the Efficacy and Safety of the FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women
Urethral pain syndrome (UPS) is defined by the occurrence of persistent or recurrent episodic urethral pain in the absence of proven infection or other obvious pathology. The objective of this study is to determine the effect of an intraurethral and vaginal laser therapy for the treatment of UPS. The hypothesis is that a significant reduction of urethral pressure pain can be achieved.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | December 2026 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult female, 18 years of age or older - Urethral pressure pain upon palpation, VAS Score = 2 - Intermittent or chronic pain in the urethra and/or the small pelvis (independent of micturition) for at least 6 months - No significant improvement of UPS from at least one previous conservative treatment (pessary, antibiotics, local oestrogens etc.) - Signed informed consent Exclusion Criteria: - Pregnancy - Treatment with Isotretinoin (Acne, Rosacea) within last 6 months - Acute urinary tract infection or other acute infection of the bladder, vagina, vulva or urinary tract detected by routine urine analysis - Positive urethral swab for Ureaplasma, Mycoplasma or Chlamydia = 6 weeks. Exception: Patients with chronic and persistent fastidious bacteria can be included six weeks after two unsuccessful treatments with antibiotics. Antibiotics therapy must also include sexual partners. - Pre-existing bladder or urethra pathology - Interstitial Cystitis - Endometriosis - Diagnosis of collagen disorders, e.g. benign joint hypermobility / Elhers-Danlos / Marfans etc. - Vesicovaginal fistula - Unwillingness or inability to complete follow-up schedule - Unwillingness or inability to give informed consent - Unwillingness or inability to complete questionnaires |
Country | Name | City | State |
---|---|---|---|
Switzerland | Cantonal Hospital Frauenfeld | Frauenfeld | Thurgau |
Lead Sponsor | Collaborator |
---|---|
Prof. Dr. Volker Viereck |
Switzerland,
Blaganje M, Scepanovic D, Zgur L, Verdenik I, Pajk F, Lukanovic A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018 May;224:153-158. doi: 10.1016/j.ejogrb.2018.03.038. Epub 2018 Mar 22. — View Citation
Fistonic I, Fistonic N. Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women: A prospective cohort study. Lasers Surg Med. 2018 Jan 23. doi: 10.1002/lsm.22789. Online ahead of print. — View Citation
Fistonic N, Fistonic I, Gustek SF, Turina IS, Marton I, Vizintin Z, Kazic M, Hreljac I, Perhavec T, Lukac M. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women--a pilot study. Lasers Med Sci. 2016 May;31(4):635-43. doi: 10.1007/s10103-016-1884-0. Epub 2016 Feb 9. — View Citation
Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015 Oct;18(5):757-63. doi: 10.3109/13697137.2015.1045485. — View Citation
Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018 Apr;21(2):148-152. doi: 10.1080/13697137.2018.1436538. Epub 2018 Feb 13. — View Citation
Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol. 2015 Apr;67(2):97-102. — View Citation
Gaspar A, Brandi H. Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency). Lasers Med Sci. 2017 Apr;32(3):685-691. doi: 10.1007/s10103-017-2170-5. Epub 2017 Feb 16. — View Citation
Gaspar A, Maestri S, Silva J, Brandi H, Luque D, Koron N, Vizintin Z. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Lasers Surg Med. 2018 Oct;50(8):802-807. doi: 10.1002/lsm.22826. Epub 2018 Apr 18. — View Citation
Gaspar A, Silva J, Silva G, Anchelerguez R, Prats J, Sagaz A, Rovere E, Alastra M, Pino J, Jauregui A, Farrugia M, Villaroel F, Guareschi J, Vega M, Biasiori E, Moyano E, La Rosa A, Hreljac I, Vizintin Z. Nonablative transurethral Erbium:YAG laser treatment for chronic prostatitis/chronic pelvic pain syndrome: A prospective comparative study. Neurourol Urodyn. 2021 Jan;40(1):278-285. doi: 10.1002/nau.24551. Epub 2020 Nov 10. — View Citation
Kaur H, Arunkalaivanan AS. Urethral pain syndrome and its management. Obstet Gynecol Surv. 2007 May;62(5):348-51; quiz 353-4. doi: 10.1097/01.ogx.0000261645.12099.2a. — View Citation
Kuszka A, Gamper M, Walser C, Kociszewski J, Viereck V. Erbium:YAG laser treatment of female stress urinary incontinence: midterm data. Int Urogynecol J. 2020 Sep;31(9):1859-1866. doi: 10.1007/s00192-019-04148-9. Epub 2019 Dec 11. — View Citation
Yoon SM, Jung JK, Lee SB, Lee T. Treatment of female urethral syndrome refractory to antibiotics. Yonsei Med J. 2002 Oct;43(5):644-51. doi: 10.3349/ymj.2002.43.5.644. — View Citation
* Note: There are 12 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of patients reprting good tolerability ("good" or "very good") of vulvar creams in combination with laser treatment | Patient satisfaction (5-item scale from "not at all" to "very good") on the use of vulvar creams | 5 months | |
Primary | Number of patients showing improvement in symptoms due to laser treatment | Reduction of urethral pressure pain upon palpation (visual analogue scale, 0-10 where 0 is none and 10 the worst), cure/improvement defined as >50% reduction compared to baseline | 5 months | |
Secondary | Number of patients showing improvement (reduction) in induration after treatment | digital testing of pelvic induration by physician (scale: high, moderate, none) compared to baseline | 5 months | |
Secondary | Number of patients showing improvement (reduction in questionnaire sum) in symptoms as assed by subjective questionnaire | subjective evaluation by validated questionnaire (Genitourinary Pain Index for Women, sum scale 0-45, the lower the value the lower the symptoms) compared to baseline | 5 months, 12 months | |
Secondary | Number of patients reporting pain during laser treatment | VAS (visual analogue scale, 0-10 where 0 is none and 10 the worst) pain score during laser treatment | 3 months | |
Secondary | Number of patients showing urethral infections before and after treatment | Analysis of urethral infections before and after treatment using urine dipstick test (positive/negative) | 5 months | |
Secondary | Number of patients reporting satisfaction with treatment outcome | subjective evaluation of improvement (patient global index fo improvement, 7-item scale from "very much worse" to "very much better"), cure/improvement defined as response "much better" or "very much better" | 5 months, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03252041 -
MRI & MRV in Pelvic Congestion Syndrome in Females
|
N/A | |
Completed |
NCT03671993 -
Clinical Effect Observation for Electrical Pudendal Nerve Stimulation in Treating Urethral Pain Syndrome
|
N/A | |
Completed |
NCT03715777 -
Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain
|
Phase 3 | |
Withdrawn |
NCT04046406 -
Pelvic Pain Treated With MR-guided Cryoanalgesia
|
N/A | |
Recruiting |
NCT06124664 -
Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
|
||
Not yet recruiting |
NCT03943381 -
Duplex US in Pelvic Congestion Syndrome in Females (PCS)
|
||
Completed |
NCT03797911 -
Efficacy of Resistive Capacitive Monopolar Radiofrequency in the Physiotherapeutic Treatment of Chronic Pelvic Pain: RCT
|
N/A | |
Not yet recruiting |
NCT06168058 -
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
|
N/A | |
Recruiting |
NCT05489133 -
Early Psychological Intervention After Rape
|
N/A | |
Not yet recruiting |
NCT04910672 -
Primary Dysmenorrhea and Osteopathic Treatment
|
N/A | |
Completed |
NCT04135118 -
Validation of the Adenomyosis Calculator
|
||
Recruiting |
NCT06102733 -
Chronic Pelvic Pain in Females and Males
|
||
Recruiting |
NCT06369545 -
Chronic Pelvic Pain Syndrome in Males
|
N/A | |
Enrolling by invitation |
NCT05513417 -
Digital Care Programs for Female Pelvic Health
|
||
Completed |
NCT06080828 -
Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women
|
N/A |